Cross-talk between interleukin 1β (IL-1β) and IL-6 signalling pathways: IL-1β selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism

Biochemical Journal

Volumn 352, Issue 3, 2000, Pages 913-919

  Shen, X ^a   Tian, Z ^a   Holtzman, M J ^a   Gao, B ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Acute phase protein; Janus kinase; Liver cells; Nuclear factor B; Protein tyrosine phosphatase

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; JANUS KINASE; PROTEASOME; STAT PROTEIN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; LIVER CELL CARCINOMA; MOLECULAR INTERACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ACUTE-PHASE PROTEINS; CYSTEINE ENDOPEPTIDASES; DNA; DNA-BINDING PROTEINS; DOWN-REGULATION; ENZYME ACTIVATION; HEPATOCYTES; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; JANUS KINASE 1; JANUS KINASE 2; LEUPEPTINS; MODELS, BIOLOGICAL; MULTIENZYME COMPLEXES; MUTATION; NF-KAPPA B; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE; PROTO-ONCOGENE PROTEINS; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

JANUS;

EID: 0034672409     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3520913     Document Type: Article

References (44)

1. Hepatic acute phase reaction in vivo and in vitro
2. Cytokines and the hepatic acute-phase response
3. The down-regulation of IL-6-stimulated fibrinogen steady state mRNA and protein levels by human recombinant IL-1 is not PGE2-dependent: Effects of IL-1 receptor antagonist (IL-1RA)
4. Cytokines and the acute phase response of the liver
5. Interleukin-6-type cytokine signalling through the gp130/JAK/STAT pathway
6. STATs and gene regulation
7. JAKs and STATs: Biological implications
8. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells
9. The rapid inactivation of nuclear tyrosine phosphorylated STAT1 depends upon a protein tyrosine phosphatase
10. Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells
11. Angiotensin II-induced tyrosine phosphorylation of signal transducers and activators of transcription 1 is regulated by Janus-activated kinase 2 and Fyn kinases and mitogen-activated protein kinase phosphatase 1
12. A nuclear protein tyrosine phosphatase is required for the inactivation of STAT1
13. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: Roles of SHP-1 and SHP-2
14. Differential regulation of the alpha/beta interferon-stimulated JAK/STAT pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1
15. Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated JAK/STAT pathway
16. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction
17. Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3
18. Regulation of interferon-γ-activated STAT1 by the ubiquitin-proteasome pathway
19. Involvement of proteasomes in regulating JAK-STAT pathways upon interleukin-2 stimulation
20. Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors
21. Termination of growth hormone pulse-induced STAT5b signaling
22. Negative regulation of the JAK/STAT pathway
23. Rapid inhibition of interleukin-6 signaling and STAT3 activation mediated by mitogen-activated protein kinases
24. The inhibition of interleukin-6-dependent STAT activation by mitogen-activated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130
25. Angiotensin II interferes with interleukin 6-induced Stat3 signaling by a pathway involving mitogen-activated protein kinase kinase 1
26. Interleukin-6 inhibits transforming growth factor-β-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways
27. 1BAR inhibits IL-6-activated STAT3 in hepatic cells by a p42/44 mitogen-activated protein kinase-dependent mechanism
28. Interleukin-1
29. Rel/NF-κB/IκB family: Intimate tales of association and dissociation
30. NF-κB: A lesson in family values
31. IκB kinase: Beginning, not the end
32. Regulation of NF-κB activation by MAP kinase cascades
33. Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFκB and AP-1 activation
34. Intedeukin-1
35. Transcription of the rat α1B adrenergic receptor gene in liver is controlled by three promoters
36. The rat α1B adrenergic receptor gene middle promoter contains multiple binding sites for sequence-specific proteins including a novel ubiquitous transcription factor
37. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors
38. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter
39. Analysis of chicken progesterone receptor function and phosphorylation using an adenovirus-mediated procedure for high-efficiency DNA transfer
40. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1
41. Interferons activate the p42/44 mitogen-activated protein kinase and JAK-STAT (Janus kinase-signal transducer and activator transcription factor) signalling pathways in hepatocytes: Differential regulation by acute ethanol via a protein kinase C-dependent mechanism
42. Characterization of the IL-6 responsive elements in the γ fibrinogen gene promoter
43. The competitive binding of STAT3 and NF-κB on an overlapping DNA binding site